Xiaobo Yang

1.0k citations

31 papers · 836 indexed · h-index 18

Co-authors: Kexin Liu Qiang Meng Changyuan Wang Huijun Sun Pengyuan Sun Xiaokui Huo Zhihao Liu Qi Liu
Topics: Drug Transport and Resistance Mechanisms (12 papers)Pharmacological Effects of Natural Compounds (5 papers)Liver Disease Diagnosis and Treatment (5 papers)
Cited by: Pharmacology Oncology Hepatology
Journals: International Journal of Molecular Sciences Neuroscience International Journal of Pharmaceutics
Partner nations: China United States

In The Last Decade

Xiaobo Yang

31 papers receiving 830 citations

Peers

Countries citing papers authored by Xiaobo Yang

Since Specialization

Citations

This map shows the geographic impact of Xiaobo Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaobo Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaobo Yang more than expected).

Fields of papers citing papers by Xiaobo Yang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaobo Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaobo Yang. The network helps show where Xiaobo Yang may publish in the future.

Co-authorship network of co-authors of Xiaobo Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaobo Yang. A scholar is included among the top collaborators of Xiaobo Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaobo Yang. Xiaobo Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A picogram BA-ELISA quantification assay for rLj-RGD3, a platelet fibrinogen receptor antagonist, in the rat plasma and its application to a pharmacokinetic study 2023 ·PLoS neglected tropical diseases ·(unknown),Zhien Liu,(unknown),Ping Yü,Xiaobo Yang,Jihong Wang,(unknown)	1
2	Resveratrol Enhances Temozolomide Efficacy in Glioblastoma Cells through Downregulated MGMT and Negative Regulators-Related STAT3 Inactivation 2023 ·International Journal of Molecular Sciences ·Mo‐Li Wu,Danyang Song,Hui Li,Nisar Ahmad,Hong Xu,Xiaobo Yang,(unknown),Xiaoxin Cheng,Sa Deng,Xiaohong Shu	16
3	Sesamin Protects against and Ameliorates Rat Intestinal Ischemia/Reperfusion Injury with Involvement of Activating Nrf2/HO‐1/NQO1 Signaling Pathway 2021 ·Oxidative Medicine and Cellular Longevity ·(unknown),Jin Wen,Marwan Almoiliqy,Yaojia Wang,Zhihao Liu,Xiaobo Yang,(unknown),Qiang Meng,Jinyong Peng,Yuan Lin,Pengyuan Sun	27
4	Protective effects of ginsenoside Rg1 against lipopolysaccharide/ d -galactosamine-induced acute liver injury in mice through inhibiting toll-like receptor 4 signaling pathway 2018 ·International Immunopharmacology ·(unknown),Xiaoguang Gao,Changyuan Wang,Xiaokui Huo,Zhihao Liu,Huijun Sun,Xiaobo Yang,Pengyuan Sun,Xiaodong Ma,Qiang Meng,Kexin Liu	43
5	Yangonin protects against cholestasis and hepatotoxity via activation of farnesoid X receptor in vivo and in vitro 2018 ·Toxicology and Applied Pharmacology ·Xiaoguang Gao,Ting Fu,Changyuan Wang,(unknown),Kexin Liu,Zhihao Liu,Huijun Sun,Xiaodong Ma,Xiaokui Huo,Xiaobo Yang,Ming Zou,Qiang Meng	29
6	Yangonin protects against non-alcoholic fatty liver disease through farnesoid X receptor 2018 ·Phytomedicine ·(unknown),Xiaobo Yang,Changyuan Wang,Kexin Liu,Zhihao Liu,Xiaodong Ma,Huijun Sun,Xiaokui Huo,Ting Fu,Qiang Meng	34
7	Process optimization of spray-dried fanhuncaoin powder for pulmonary drug delivery and its pharmacokinetic evaluation in rats 2018 ·Drug Development and Industrial Pharmacy ·Xiaobo Wang,Yinan Wang,Ronggang Xi,Yuanyuan Wang,Xiaobo Yang	2
8	Hepatoprotective effect of ginsenoside Rg1 from Panax ginseng on carbon tetrachloride‐induced acute liver injury by activating Nrf2 signaling pathway in mice 2018 ·Environmental Toxicology ·(unknown),Xiaoguang Gao,Changyuan Wang,Xiaokui Huo,Zhihao Liu,Huijun Sun,Xiaobo Yang,Pengyuan Sun,Xiaodong Ma,Qiang Meng,Kexin Liu	59
9	P-gp is involved in the intestinal absorption and biliary excretion of afatinib in vitro and in rats 2017 ·Pharmacological Reports ·Yan Zhang,Changyuan Wang,Zhihao Liu,Qiang Meng,Xiaokui Huo,Qi Liu,Pengyuan Sun,Xiaobo Yang,Huijun Sun,Xiaodong Ma,Kexin Liu	18
10	P-gp, MRP2 and OAT1/OAT3 mediate the drug-drug interaction between resveratrol and methotrexate 2016 ·Toxicology and Applied Pharmacology ·(unknown),Zhihao Liu,Changyuan Wang,Qiang Meng,Xiaokui Huo,Qi Liu,Huijun Sun,Pengyuan Sun,Xiaobo Yang,Xiaodong Ma,Kexin Liu	52
11	P-gp Inhibition-Based Strategies for Modulating Pharmacokinetics of Anticancer Drugs: An Update 2016 ·Current Drug Metabolism ·Xiaobo Yang,Kexin Liu	41
12	The role of connexin43 in hemorrhagic transformation after thrombolysis in vivo and in vitro 2016 ·Neuroscience ·Xiaobo Yang,Heling Chu,Yuping Tang,Qiang Dong	13
13	Calycosin attenuates triglyceride accumulation and hepatic fibrosis in murine model of non-alcoholic steatohepatitis via activating farnesoid X receptor 2016 ·Phytomedicine ·(unknown),Qiang Meng,Changyuan Wang,Zhihao Liu,Qi Liu,Huijun Sun,Pengyuan Sun,Xiaobo Yang,Xiaokui Huo,Jinyong Peng,Kexin Liu	56
14	Enhancement effect of resveratrol on the intestinal absorption of bestatin by regulating PEPT1, MDR1 and MRP2 in vivo and in vitro 2015 ·International Journal of Pharmaceutics ·(unknown),Zhihao Liu,Xiaokui Huo,Changyuan Wang,Qiang Meng,Qi Liu,Huijun Sun,Pengyuan Sun,Xiaobo Yang,Xiaohong Shu,Kexin Liu	21
15	Bezafibrate–mizoribine interaction: Involvement of organic anion transporters OAT1 and OAT3 in rats 2015 ·European Journal of Pharmaceutical Sciences ·Yuan Feng,Changyuan Wang,Qi Liu,Qiang Meng,Xiaokui Huo,Zhihao Liu,Pengyuan Sun,Xiaobo Yang,Huijun Sun,Jianhua Qin,Kexin Liu	13
16	PEPT1- and OAT1/3-mediated drug–drug interactions between bestatin and cefixime in vivo and in vitro in rats, and in vitro in human 2014 ·European Journal of Pharmaceutical Sciences ·Li Wang,Changyuan Wang,Qi Liu,Qiang Meng,Xiaokui Huo,Pengyuan Sun,Xiaobo Yang,Huijun Sun,Yuhong Zhen,Jinyong Peng,Xiaochi Ma,Kexin Liu	23
17	Protective Effects of Calycosin Against CCl4-Induced Liver Injury with Activation of FXR and STAT3 in Mice 2014 ·Pharmaceutical Research ·Han Y. H. Chen,Qiang Meng,Changyuan Wang,Qi Liu,Huijun Sun,Xiaokui Huo,Pengyuan Sun,Xiaobo Yang,Jinyong Peng,Kexin Liu	44
18	Dasatinib reverses the multidrug resistance of breast cancer MCF-7 cells to doxorubicin by downregulating P-gp expression via inhibiting the activation of ERK signaling pathway 2014 ·Cancer Biology & Therapy ·Ting Chen,Changyuan Wang,Qi Liu,Qiang Meng,Huijun Sun,Xiaokui Huo,Pengyuan Sun,Jinyong Peng,Zhihao Liu,Xiaobo Yang,Kexin Liu	78
19	Dioscin enhances methotrexate absorption by down-regulating MDR1 in vitro and in vivo 2014 ·Toxicology and Applied Pharmacology ·Lijuan Wang,Changyuan Wang,Jinyong Peng,Qi Liu,Qiang Meng,Huijun Sun,Xiaokui Huo,Pengyuan Sun,Xiaobo Yang,Yuhong Zhen,Kexin Liu	14
20	Effect and the probable mechanisms of silibinin in regulating insulin resistance in the liver of rats with non-alcoholic fatty liver 2013 ·Brazilian Journal of Medical and Biological Research ·Jiayin Yao,Min Zhi,Xiang Gao,Pinjin Hu,Chujun Li,Xiaobo Yang	73

About Xiaobo Yang

Xiaobo Yang is a scholar working on Pharmacology, Oncology and Pharmaceutical Science, having authored 31 papers that have together received 836 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (12 papers), Pharmacological Effects of Natural Compounds (5 papers) and Liver Disease Diagnosis and Treatment (5 papers). The work is most often cited by research in Pharmacology (235 citations), Oncology (262 citations) and Hepatology (71 citations). Xiaobo Yang has collaborated with scholars based in China and United States. Frequent co-authors include Kexin Liu, Qiang Meng, Changyuan Wang, Huijun Sun, Pengyuan Sun, Xiaokui Huo, Zhihao Liu, Qi Liu, Jinyong Peng and Xiaodong Ma. Their work appears in journals such as International Journal of Molecular Sciences, Neuroscience and International Journal of Pharmaceutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact